NEVE ILAN, Israel, Oct. 10, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that it is postponing the previously announced Investor Day scheduled for Tuesday, Oct. 17, 2023, at the Nasdaq in New York City.
“It is with sadness that we announce the decision to postpone our Investor Day,” said Erez Meltzer, Chief Executive Officer of Nanox. “We carefully made this decision in light of the horrifying recent events unfolding in Israel as an act of solidarity. Our business, in particular our US operations and go to market strategy continue as planned, and Nanox employees are working safely as we continue to monitor and adapt to the evolving situation. We will continue to monitor the situation and provide updates as necessary. We plan to announce the new date for the Investor Day and provide additional information in the coming weeks.”
About Nanox:
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC - a multi-source Digital Tomosynthesis system that is cost-effective, and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease, (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision.
CONTACTS: Media Contact: Rachael Roselli ICR Westwicke NanoxPR@icrinc.com Investor Contact: Mike Cavanaugh ICR Westwicke mike.cavanaugh@westwicke.com
